Lord, Abbett & Co
DCPH

Lord, Abbett & Co’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Lord, Abbett & Co’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-342,274
Closed -$19.5M – 707
2020
Q4 		$19.5M Sell
342,274
-57,725
-14% -$3.42M 0.05% 414
2020
Q3 		$20.5M Buy
399,999
+15,194
+4% +$744K 0.07% 375
2020
Q2 		$23M Sell
384,805
-9,215
-2% -$493K 0.08% 349
2020
Q1 		$16.2M Sell
394,020
-197,017
-33% -$10.9M 0.07% 349
2019
Q4 		$36.8M Buy
591,037
+258,717
+78% +$12.3M 0.12% 260
2019
Q3 		$11.3M Sell
332,320
-22,183
-6% -$657K 0.04% 504
2019
Q2 		$7.99M Buy
354,503
+46,371
+15% +$1.09M 0.03% 597
2019
Q1 		$7.15M Buy
308,132
+71,525
+30% +$1.87M 0.02% 613
2018
Q4 		$4.97M Sell
236,607
-125,417
-35% -$3.08M 0.02% 651
2018
Q3 		$14M Buy
362,024
+3,439
+1% +$127K 0.04% 564
2018
Q2 		$14.1M Buy
358,585
+8,254
+2% +$243K 0.04% 557
2018
Q1 		$7.02M Buy
350,331
+80,207
+30% +$2.03M 0.02% 673
2017
Q4 		$6.12M Buy
270,124
+90,124
+50% +$1.76M 0.02% 719
2017
Q3 		$3.42M Buy
+180,000
New +$3.3M 0.01% 811

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co's DCPH Position: Q1 2021 in Review

Lord, Abbett & Co sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 342,274 shares — an estimated $19.5M sold.

Lord, Abbett & Co first reported a position in DCPH in Q3 2017 and held it in 14 quarters. The position peaked at $36.8M in Q4 2019. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Lord, Abbett & Co reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 342,274 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $19.5M.
  • Lord, Abbett & Co first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 14 quarters.
  • Lord, Abbett & Co's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $36.8M in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Lord, Abbett & Co's 13F filing for Q1 2021, filed 11 May 2021.